Bombus pyrosoma isolate SC7728 linkage group LG5, ASM1482585v1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Apoidea; Apidae; Bombus; Melanobombus.
Genus-wide characterization of bumblebee genomes provides insights into their evolution and variation in ecological and behavioral traits
Publication Status: Available-Online prior to print
REFSEQ INFORMATION: The reference sequence is identical to\nCM026129.1.\nAssembly name: ASM1482585v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Chinese Academy of\nAgricultural Sciences on 2020/10/02. The original whole-genome\nshotgun project has the accession JACXIN000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Chinese Academy of Agricultural Sciences\nAssembly Date :: DEC-2017\nAssembly Method :: DISCOVAR de novo v. 52488\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 100x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Bombus pyrosoma Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
piggyBac transposable element-derived protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
zinc finger protein 624-like, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
zinc finger protein 624-like, transcript variant X2
golgin subfamily A member 6-like protein 22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53% coverage of the annotated genomic feature by RNAseq alignments
putative sodium-coupled neutral amino acid transporter 11, transcript variant X2
putative sodium-coupled neutral amino acid transporter 11, transcript variant X1
putative sodium-coupled neutral amino acid transporter 11, transcript variant X6
putative sodium-coupled neutral amino acid transporter 11, transcript variant X7
putative sodium-coupled neutral amino acid transporter 11, transcript variant X5
putative sodium-coupled neutral amino acid transporter 11, transcript variant X4
putative sodium-coupled neutral amino acid transporter 11, transcript variant X3
uncharacterized LOC122567681, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122567681, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
putative sodium-coupled neutral amino acid transporter 11 isoform X2
putative sodium-coupled neutral amino acid transporter 11 isoform X1
putative sodium-coupled neutral amino acid transporter 11 isoform X3
mitogen-activated protein kinase kinase kinase 7-like, transcript variant X2
mitogen-activated protein kinase kinase kinase 7-like, transcript variant X3
mitogen-activated protein kinase kinase kinase 7-like, transcript variant X1
mitogen-activated protein kinase kinase kinase 7-like isoform X1
mitogen-activated protein kinase kinase kinase 7-like isoform X2
protein phosphatase inhibitor 2-like, transcript variant X1
protein phosphatase inhibitor 2-like isoform X1
protein phosphatase inhibitor 2-like, transcript variant X2
protein phosphatase inhibitor 2-like isoform X2
charged multivesicular body protein 1b, transcript variant X1
charged multivesicular body protein 1b, transcript variant X2
uncharacterized LOC122567675, transcript variant X1
uncharacterized LOC122567675, transcript variant X2
uncharacterized protein LOC122567675 isoform X2
uncharacterized protein LOC122567675 isoform X1
general odorant-binding protein 71, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
general odorant-binding protein 71, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
general odorant-binding protein 71, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
general odorant-binding protein 71 isoform X2
general odorant-binding protein 71 isoform X3
general odorant-binding protein 71 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma-like
F-actin-capping protein subunit beta, transcript variant X2
F-actin-capping protein subunit beta isoform X2
F-actin-capping protein subunit beta, transcript variant X1
F-actin-capping protein subunit beta isoform X1
eukaryotic translation initiation factor 5A, transcript variant X3
eukaryotic translation initiation factor 5A, transcript variant X1
eukaryotic translation initiation factor 5A, transcript variant X2
eukaryotic translation initiation factor 5A
uroporphyrinogen decarboxylase, transcript variant X2
uroporphyrinogen decarboxylase, transcript variant X1
FACT complex subunit Ssrp1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
FACT complex subunit Ssrp1, transcript variant X2
FACT complex subunit Ssrp1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
golgin subfamily A member 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
golgin subfamily A member 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
golgin subfamily A member 2-like, transcript variant X1
golgin subfamily A member 2-like isoform X2
golgin subfamily A member 2-like isoform X1
probable 26S proteasome non-ATPase regulatory subunit 3, transcript variant X1
probable 26S proteasome non-ATPase regulatory subunit 3, transcript variant X2
probable 26S proteasome non-ATPase regulatory subunit 3
growth arrest-specific protein 1-like, transcript variant X1
growth arrest-specific protein 1-like, transcript variant X2
zinc finger protein 729-like, transcript variant X2
zinc finger protein 729-like, transcript variant X1
zinc finger protein 729-like, transcript variant X3
zinc finger protein Xfin-like isoform X3
tight junction protein ZO-1, transcript variant X4
tight junction protein ZO-1, transcript variant X6
tight junction protein ZO-1, transcript variant X5
mitochondrial glutamate carrier 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
mitochondrial glutamate carrier 1-like, transcript variant X3
tight junction protein ZO-1, transcript variant X7
tight junction protein ZO-1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
tight junction protein ZO-1, transcript variant X1
tight junction protein ZO-1, transcript variant X2
mitochondrial glutamate carrier 1-like, transcript variant X1
mitochondrial glutamate carrier 1-like isoform X1
mitochondrial glutamate carrier 1-like, transcript variant X4
mitochondrial glutamate carrier 1-like isoform X2
uncharacterized protein CG4449, transcript variant X2
uncharacterized protein CG4449, transcript variant X4
uncharacterized protein CG4449, transcript variant X3
uncharacterized protein CG4449, transcript variant X1
uncharacterized protein CG4449 isoform X1
uncharacterized protein CG4449, transcript variant X5
uncharacterized protein CG4449 isoform X2
uncharacterized protein CG4449 isoform X3
uncharacterized protein CG4449 isoform X4
histone H4 transcription factor-like, transcript variant X2
histone H4 transcription factor-like, transcript variant X3
histone H4 transcription factor-like, transcript variant X1
histone H4 transcription factor-like isoform X3
histone H4 transcription factor-like isoform X2
histone H4 transcription factor-like isoform X1
tRNA modification GTPase GTPBP3, mitochondrial, transcript variant X4
tRNA modification GTPase GTPBP3, mitochondrial, transcript variant X3
tRNA modification GTPase GTPBP3, mitochondrial, transcript variant X1
tRNA modification GTPase GTPBP3, mitochondrial, transcript variant X2
tRNA modification GTPase GTPBP3, mitochondrial isoform X1
tRNA modification GTPase GTPBP3, mitochondrial isoform X2
tRNA modification GTPase GTPBP3, mitochondrial isoform X3
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X2
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X1
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X3
TP53-regulated inhibitor of apoptosis 1-like isoform X2
TP53-regulated inhibitor of apoptosis 1-like isoform X1
TP53-regulated inhibitor of apoptosis 1-like isoform X3
7-methylguanosine phosphate-specific 5'-nucleotidase
cholesterol 7-desaturase nvd, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cholesterol 7-desaturase nvd, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
MATH and LRR domain-containing protein PFE0570w-like, transcript variant X4
MATH and LRR domain-containing protein PFE0570w-like, transcript variant X1
MATH and LRR domain-containing protein PFE0570w-like, transcript variant X2
MATH and LRR domain-containing protein PFE0570w-like, transcript variant X3
uncharacterized protein LOC122567970 isoform X2
MATH and LRR domain-containing protein PFE0570w-like isoform X1
eukaryotic translation initiation factor 3 subunit J
acidic mammalian chitinase, transcript variant X1
acidic mammalian chitinase, transcript variant X2
uncharacterized LOC122567975, transcript variant X1
uncharacterized LOC122567975, transcript variant X2
transmembrane ascorbate-dependent reductase CYB561-like, transcript variant X2
transmembrane ascorbate-dependent reductase CYB561-like, transcript variant X1
transmembrane ascorbate-dependent reductase CYB561-like, transcript variant X3
transmembrane ascorbate-dependent reductase CYB561-like isoform X1
transmembrane ascorbate-dependent reductase CYB561-like isoform X2
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial, transcript variant X2
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial, transcript variant X3
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial, transcript variant X1
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial isoform X1
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial isoform X2
recQ-mediated genome instability protein 1-like, transcript variant X2
recQ-mediated genome instability protein 1-like, transcript variant X3
recQ-mediated genome instability protein 1-like, transcript variant X1
recQ-mediated genome instability protein 1-like isoform X2
recQ-mediated genome instability protein 1-like isoform X1
recQ-mediated genome instability protein 1-like isoform X3
uncharacterized LOC122567375, transcript variant X2
uncharacterized LOC122567375, transcript variant X1
uncharacterized LOC122567375, transcript variant X8
uncharacterized LOC122567375, transcript variant X9
uncharacterized LOC122567375, transcript variant X11
uncharacterized LOC122567375, transcript variant X10
uncharacterized LOC122567375, transcript variant X3
uncharacterized LOC122567375, transcript variant X5
uncharacterized LOC122567375, transcript variant X6
uncharacterized LOC122567375, transcript variant X4
uncharacterized LOC122567375, transcript variant X12
uncharacterized LOC122567375, transcript variant X13
uncharacterized LOC122567375, transcript variant X7
uncharacterized protein LOC122567375 isoform X1
uncharacterized protein LOC122567375 isoform X2
uncharacterized protein LOC122567375 isoform X3
kynurenine/alpha-aminoadipate aminotransferase, mitochondrial-like
serine/arginine repetitive matrix protein 2, transcript variant X1
serine/arginine repetitive matrix protein 2, transcript variant X3
serine/arginine repetitive matrix protein 2, transcript variant X2
serine/arginine repetitive matrix protein 2, transcript variant X5
serine/arginine repetitive matrix protein 2, transcript variant X4
serine/arginine repetitive matrix protein 2, transcript variant X6
serine/arginine repetitive matrix protein 2 isoform X1
serine/arginine repetitive matrix protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CCA tRNA nucleotidyltransferase 1, mitochondrial, transcript variant X1
CCA tRNA nucleotidyltransferase 1, mitochondrial, transcript variant X2
CCA tRNA nucleotidyltransferase 1, mitochondrial isoform X1
CCA tRNA nucleotidyltransferase 1, mitochondrial isoform X2
transcription initiation factor IIA subunit 1, transcript variant X2
transcription initiation factor IIA subunit 1, transcript variant X1
transcription initiation factor IIA subunit 1 isoform X2
transcription initiation factor IIA subunit 1 isoform X1
transcription initiation factor IIA subunit 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
SR-related and CTD-associated factor 4, transcript variant X3
SR-related and CTD-associated factor 4, transcript variant X2
SR-related and CTD-associated factor 4, transcript variant X1
proteasome assembly chaperone 2, transcript variant X3
proteasome assembly chaperone 2, transcript variant X2
proteasome assembly chaperone 2, transcript variant X1
translocon-associated protein subunit delta
pleckstrin homology domain-containing family J member 1-like, transcript variant X2
pleckstrin homology domain-containing family J member 1-like, transcript variant X1
pleckstrin homology domain-containing family J member 1-like isoform X2
pleckstrin homology domain-containing family J member 1-like isoform X1
probable E3 ubiquitin-protein ligase MGRN1, transcript variant X1
probable E3 ubiquitin-protein ligase MGRN1, transcript variant X2
probable E3 ubiquitin-protein ligase MGRN1 isoform X1
probable E3 ubiquitin-protein ligase MGRN1 isoform X2
60S ribosomal protein L10, transcript variant X1
60S ribosomal protein L10, transcript variant X2
mediator of RNA polymerase II transcription subunit 9
GTP-binding protein 1, transcript variant X2
GTP-binding protein 1, transcript variant X1
trafficking protein particle complex subunit 8, transcript variant X2
trafficking protein particle complex subunit 8, transcript variant X1
trafficking protein particle complex subunit 8, transcript variant X3
trafficking protein particle complex subunit 8 isoform X1
trafficking protein particle complex subunit 8 isoform X2
trafficking protein particle complex subunit 8 isoform X3
dynein axonemal light chain 4-like, transcript variant X2
dynein axonemal light chain 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X5
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X4
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X3
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X2
probable cytosolic Fe-S cluster assembly factor AGAP009023 isoform X2
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X1
probable cytosolic Fe-S cluster assembly factor AGAP009023 isoform X1
probable cytosolic Fe-S cluster assembly factor AGAP009023 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
WD repeat domain-containing protein 83, transcript variant X1
WD repeat domain-containing protein 83, transcript variant X2
WD repeat domain-containing protein 83 isoform X2
WD repeat domain-containing protein 83 isoform X1
low-density lipoprotein receptor-like, transcript variant X1
low-density lipoprotein receptor-like, transcript variant X2
low-density lipoprotein receptor-like, transcript variant X3
low-density lipoprotein receptor-like, transcript variant X7
low-density lipoprotein receptor-like, transcript variant X4
low-density lipoprotein receptor-like, transcript variant X5
very low-density lipoprotein receptor-like isoform X1
very low-density lipoprotein receptor-like isoform X2
low-density lipoprotein receptor-like isoform X4
low-density lipoprotein receptor-like isoform X3
low-density lipoprotein receptor-like isoform X5
very low-density lipoprotein receptor-like isoform X7
low-density lipoprotein receptor-like, transcript variant X6
very low-density lipoprotein receptor-like isoform X6
ribosome production factor 2 homolog, transcript variant X2
ribosome production factor 2 homolog, transcript variant X1
ribosome production factor 2 homolog isoform X1
ribosome production factor 2 homolog isoform X2
probable cysteine--tRNA ligase, mitochondrial, transcript variant X4
probable cysteine--tRNA ligase, mitochondrial, transcript variant X2
probable cysteine--tRNA ligase, mitochondrial, transcript variant X1
probable cysteine--tRNA ligase, mitochondrial isoform X4
probable cysteine--tRNA ligase, mitochondrial isoform X1
probable cysteine--tRNA ligase, mitochondrial isoform X2
probable cysteine--tRNA ligase, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
probable cysteine--tRNA ligase, mitochondrial, transcript variant X5
probable cysteine--tRNA ligase, mitochondrial isoform X3
probable cysteine--tRNA ligase, mitochondrial isoform X5
RNA polymerase II-associated protein 3, transcript variant X2
RNA polymerase II-associated protein 3, transcript variant X3
RNA polymerase II-associated protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
paired box pox-neuro protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
paired box pox-neuro protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122567562, transcript variant X1
uncharacterized LOC122567562, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
regulator of microtubule dynamics protein 1-like, transcript variant X1
regulator of microtubule dynamics protein 1-like, transcript variant X3
regulator of microtubule dynamics protein 1-like, transcript variant X2
regulator of microtubule dynamics protein 1-like isoform X1
regulator of microtubule dynamics protein 1-like isoform X2
uncharacterized LOC122567552, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122567552, transcript variant X1
uncharacterized protein LOC122567552 isoform X2
uncharacterized protein LOC122567552 isoform X1
FGGY carbohydrate kinase domain-containing protein
uncharacterized LOC122567541, transcript variant X7
uncharacterized LOC122567541, transcript variant X8
uncharacterized LOC122567541, transcript variant X4
uncharacterized protein LOC122567541 isoform X4
uncharacterized LOC122567564, transcript variant X2
uncharacterized LOC122567564, transcript variant X1
uncharacterized LOC122567541, transcript variant X11
uncharacterized LOC122567541, transcript variant X10
uncharacterized LOC122567541, transcript variant X12
uncharacterized LOC122567541, transcript variant X6
uncharacterized LOC122567541, transcript variant X9
uncharacterized LOC122567541, transcript variant X1
uncharacterized LOC122567541, transcript variant X2
uncharacterized protein LOC122567541 isoform X1
uncharacterized protein LOC122567541 isoform X2
uncharacterized protein LOC122567541 isoform X8
uncharacterized protein LOC122567541 isoform X6
uncharacterized protein LOC122567541 isoform X9
uncharacterized LOC122567541, transcript variant X3
uncharacterized protein LOC122567541 isoform X3
uncharacterized LOC122567541, transcript variant X5
uncharacterized protein LOC122567541 isoform X5
uncharacterized protein LOC122567541 isoform X7
uncharacterized LOC122567561, transcript variant X5
uncharacterized LOC122567561, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122567561, transcript variant X6
uncharacterized LOC122567561, transcript variant X1
uncharacterized LOC122567561, transcript variant X3
uncharacterized LOC122567561, transcript variant X2
uncharacterized protein LOC122567561 isoform X3
uncharacterized protein LOC122567561 isoform X1
uncharacterized protein LOC122567561 isoform X2
uncharacterized protein LOC122567561 isoform X4
uncharacterized LOC122567563, transcript variant X3
uncharacterized LOC122567563, transcript variant X1
uncharacterized LOC122567563, transcript variant X4
uncharacterized LOC122567563, transcript variant X2
A-kinase anchor protein 10, mitochondrial, transcript variant X3
A-kinase anchor protein 10, mitochondrial, transcript variant X1
A-kinase anchor protein 10, mitochondrial, transcript variant X2
A-kinase anchor protein 10, mitochondrial isoform X1
A-kinase anchor protein 10, mitochondrial isoform X2
A-kinase anchor protein 10, mitochondrial isoform X3
putative 28S ribosomal protein S5, mitochondrial
homeobox protein Nkx-2.4, transcript variant X2
homeobox protein Nkx-2.4, transcript variant X3
homeobox protein Nkx-2.4, transcript variant X4
homeobox protein Nkx-2.4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122567942, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122567942, transcript variant X2
uncharacterized LOC122567942, transcript variant X3
luciferin 4-monooxygenase, transcript variant X2
luciferin 4-monooxygenase, transcript variant X1
luciferin 4-monooxygenase, transcript variant X3
luciferin 4-monooxygenase, transcript variant X4
3'(2'),5'-bisphosphate nucleotidase 1, transcript variant X1
3'(2'),5'-bisphosphate nucleotidase 1, transcript variant X2
dimethyladenosine transferase 2, mitochondrial, transcript variant X1
dimethyladenosine transferase 2, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dimethyladenosine transferase 2, mitochondrial isoform X1
dimethyladenosine transferase 2, mitochondrial isoform X2
transmembrane protein 179, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transmembrane protein 179, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein distal antenna-like, transcript variant X1
protein distal antenna-like, transcript variant X2
protein distal antenna-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein distal antenna-like, transcript variant X4
protein distal antenna-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dynein regulatory complex subunit 7-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dynein regulatory complex subunit 7-like, transcript variant X4
dynein regulatory complex subunit 7-like, transcript variant X8
dynein regulatory complex subunit 7-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dynein regulatory complex subunit 7-like isoform X3
dynein regulatory complex subunit 7-like, transcript variant X6
dynein regulatory complex subunit 7-like, transcript variant X1
dynein regulatory complex subunit 7-like, transcript variant X2
dynein regulatory complex subunit 7-like, transcript variant X3
dynein regulatory complex subunit 7-like, transcript variant X5
dynein regulatory complex subunit 7-like, transcript variant X9
dynein regulatory complex subunit 7-like, transcript variant X12
dynein regulatory complex subunit 7-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dynein regulatory complex subunit 7-like isoform X1
dynein regulatory complex subunit 7-like isoform X2
dynein regulatory complex subunit 7-like isoform X4
FERM domain-containing protein 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
FERM domain-containing protein 8, transcript variant X1
FERM domain-containing protein 8 isoform X1
FERM domain-containing protein 8 isoform X2
FERM domain-containing protein 8, transcript variant X3
FERM domain-containing protein 8 isoform X3
eukaryotic initiation factor 4A-III, transcript variant X2
eukaryotic initiation factor 4A-III, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
metastasis-associated protein MTA3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
metastasis-associated protein MTA3, transcript variant X1
metastasis-associated protein MTA3, transcript variant X2
metastasis-associated protein MTA3, transcript variant X3
metastasis-associated protein MTA3 isoform X1
metastasis-associated protein MTA3 isoform X2
metastasis-associated protein MTA3 isoform X3
metastasis-associated protein MTA3 isoform X4
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF01296
splicing factor 3B subunit 2, transcript variant X2
splicing factor 3B subunit 2, transcript variant X1
GPI ethanolamine phosphate transferase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
GPI ethanolamine phosphate transferase 1-like, transcript variant X2
GPI ethanolamine phosphate transferase 1-like isoform X1
GPI ethanolamine phosphate transferase 1-like isoform X2
putative OPA3-like protein CG13603, transcript variant X1
putative OPA3-like protein CG13603, transcript variant X2
centrosomal protein CCDC61-like, transcript variant X1
centrosomal protein CCDC61-like, transcript variant X3
centrosomal protein CCDC61-like, transcript variant X2
centrosomal protein CCDC61-like isoform X1
centrosomal protein CCDC61-like isoform X3
centrosomal protein CCDC61-like isoform X2
probable glucosamine 6-phosphate N-acetyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122567588, transcript variant X1
uncharacterized protein LOC122567588 isoform X1
uncharacterized LOC122567588, transcript variant X2
uncharacterized protein LOC122567588 isoform X2
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X3
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X2
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X1
bromodomain adjacent to zinc finger domain protein 1A isoform X3
bromodomain adjacent to zinc finger domain protein 1A isoform X2
bromodomain adjacent to zinc finger domain protein 1A isoform X1
probable DNA-directed RNA polymerase III subunit RPC6
uncharacterized LOC122567586, transcript variant X1
uncharacterized LOC122567586, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial
uncharacterized protein PF11_0213-like, transcript variant X1
uncharacterized protein PF11_0213-like, transcript variant X2
uncharacterized protein PF11_0213-like, transcript variant X4
uncharacterized protein PF11_0213-like, transcript variant X3
uncharacterized protein PF11_0213-like, transcript variant X5
uncharacterized protein PF11_0213-like, transcript variant X6
uncharacterized protein PF11_0213-like, transcript variant X7
uncharacterized protein PF11_0213-like isoform X1
uncharacterized protein PF11_0213-like isoform X2
uncharacterized protein PF11_0213-like isoform X3
uncharacterized protein PF11_0213-like isoform X4
uncharacterized protein PFB0145c-like, transcript variant X2
uncharacterized protein PFB0145c-like, transcript variant X1
DNA replication licensing factor Mcm5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DNA replication licensing factor Mcm5-like, transcript variant X1
DNA replication licensing factor Mcm5-like
aldo-keto reductase family 1 member A1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
aldo-keto reductase family 1 member A1-like, transcript variant X1
aldo-keto reductase family 1 member A1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
aldo-keto reductase family 1 member A1-like, transcript variant X2
aldo-keto reductase family 1 member A1-like
rho GTPase-activating protein gacF-like, transcript variant X2
rho GTPase-activating protein gacF-like, transcript variant X4
rho GTPase-activating protein gacF-like, transcript variant X1
rho GTPase-activating protein gacF-like, transcript variant X3
rho GTPase-activating protein gacF-like isoform X1
uncharacterized protein LOC122567569 isoform X4
rho GTPase-activating protein gacF-like isoform X2
uncharacterized protein LOC122567569 isoform X3
E3 ubiquitin-protein ligase synoviolin A
serine/threonine-protein phosphatase 4 regulatory subunit 3
cilia- and flagella-associated protein 36
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
LHFPL tetraspan subfamily member 5 protein
vacuolar fusion protein MON1 homolog A, transcript variant X2
vacuolar fusion protein MON1 homolog A, transcript variant X1
uncharacterized LOC122567482, transcript variant X2
uncharacterized LOC122567482, transcript variant X1
uncharacterized LOC122567482, transcript variant X3
uncharacterized protein LOC122567482 isoform X2
uncharacterized protein LOC122567482 isoform X1
uncharacterized protein LOC122567482 isoform X3
replication protein A 70 kDa DNA-binding subunit
complement component 1 Q subcomponent-binding protein, mitochondrial
ras-related protein Rab-43, transcript variant X1
ras-related protein Rab-43, transcript variant X2
uncharacterized LOC122567479, transcript variant X5
uncharacterized LOC122567479, transcript variant X3
uncharacterized LOC122567479, transcript variant X2
uncharacterized LOC122567479, transcript variant X1
uncharacterized LOC122567479, transcript variant X4
uncharacterized protein LOC122567479 isoform X1
uncharacterized protein LOC122567479 isoform X2
RRP15-like protein, transcript variant X1
RRP15-like protein, transcript variant X2
RRP15-like protein, transcript variant X3
RRP15-like protein, transcript variant X4
RRP15-like protein, transcript variant X7
RRP15-like protein, transcript variant X11
RRP15-like protein, transcript variant X10
RRP15-like protein, transcript variant X9
RRP15-like protein, transcript variant X5
RRP15-like protein, transcript variant X6
RRP15-like protein, transcript variant X8
ADP-ribosylation factor-binding protein GGA3, transcript variant X1
ADP-ribosylation factor-binding protein GGA3, transcript variant X2
ADP-ribosylation factor-binding protein GGA3 isoform X1
ADP-ribosylation factor-binding protein GGA3 isoform X2
target of rapamycin complex subunit lst8
SAP30-binding protein, transcript variant X5
SAP30-binding protein, transcript variant X7
SAP30-binding protein, transcript variant X6
SAP30-binding protein, transcript variant X4
SAP30-binding protein, transcript variant X1
SAP30-binding protein, transcript variant X3
SAP30-binding protein, transcript variant X2
SAP30-binding protein, transcript variant X8
SAP30-binding protein, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dnaJ homolog subfamily C member 17, transcript variant X2
dnaJ homolog subfamily C member 17, transcript variant X4
dnaJ homolog subfamily C member 17, transcript variant X3
dnaJ homolog subfamily C member 17, transcript variant X1
2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
39S ribosomal protein L17, mitochondrial
E3 ubiquitin-protein ligase RNF34, transcript variant X3
E3 ubiquitin-protein ligase RNF34, transcript variant X2
E3 ubiquitin-protein ligase RNF34, transcript variant X4
E3 ubiquitin-protein ligase RNF34, transcript variant X7
E3 ubiquitin-protein ligase RNF34, transcript variant X6
E3 ubiquitin-protein ligase RNF34, transcript variant X5
E3 ubiquitin-protein ligase RNF34, transcript variant X1
E3 ubiquitin-protein ligase RNF34 isoform X3
E3 ubiquitin-protein ligase RNF34 isoform X2
E3 ubiquitin-protein ligase RNF34 isoform X1
E3 ubiquitin-protein ligase RNF34 isoform X4
homeobox protein AKR-like, transcript variant X2
homeobox protein AKR-like, transcript variant X3
homeobox protein AKR-like, transcript variant X1
uncharacterized LOC122567508, transcript variant X1
uncharacterized LOC122567508, transcript variant X2
uncharacterized LOC122567505, transcript variant X1
uncharacterized LOC122567505, transcript variant X2
cytoplasmic tRNA 2-thiolation protein 2, transcript variant X4
cytoplasmic tRNA 2-thiolation protein 2, transcript variant X1
cytoplasmic tRNA 2-thiolation protein 2, transcript variant X3
cytoplasmic tRNA 2-thiolation protein 2, transcript variant X2
39S ribosomal protein L40, mitochondrial
neuroparsin-A-like, transcript variant X2
neuroparsin-A-like, transcript variant X3
neuroparsin-A-like, transcript variant X1
essential MCU regulator, mitochondrial, transcript variant X7
myb-like protein X, transcript variant X2
myb-like protein X, transcript variant X1
myb-like protein X, transcript variant X3
myb-like protein X, transcript variant X4
myb-like protein X, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
essential MCU regulator, mitochondrial, transcript variant X5
essential MCU regulator, mitochondrial, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
essential MCU regulator, mitochondrial, transcript variant X6
essential MCU regulator, mitochondrial, transcript variant X3
essential MCU regulator, mitochondrial, transcript variant X2
essential MCU regulator, mitochondrial, transcript variant X4
essential MCU regulator, mitochondrial, transcript variant X1
protein flightless-1, transcript variant X1
protein flightless-1, transcript variant X2
protein flightless-1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 482 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein flightless-1, transcript variant X4
protein flightless-1, transcript variant X5
mitochondrial import receptor subunit TOM22 homolog
M protein, serotype 6-like, transcript variant X2
uncharacterized protein LOC122567528 isoform X2
M protein, serotype 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
M protein, serotype 6-like, transcript variant X3
M protein, serotype 6-like, transcript variant X4
M protein, serotype 6-like, transcript variant X5
hemicentin-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
hemicentin-1-like, transcript variant X4
hemicentin-1-like, transcript variant X3
hemicentin-1-like, transcript variant X2
hemicentin-2-like, transcript variant X2
hemicentin-2-like, transcript variant X1
elongation of very long chain fatty acids protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
elongation of very long chain fatty acids protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
elongation of very long chain fatty acids protein 1-like
cysteine sulfinic acid decarboxylase-like, transcript variant X1
cysteine sulfinic acid decarboxylase-like isoform X1
cysteine sulfinic acid decarboxylase-like, transcript variant X2
cysteine sulfinic acid decarboxylase-like isoform X2
protein UXT homolog, transcript variant X2
protein UXT homolog, transcript variant X1
doublesex- and mab-3-related transcription factor 1Y-like, transcript variant X8
doublesex- and mab-3-related transcription factor 1Y-like, transcript variant X15
doublesex- and mab-3-related transcription factor 1Y-like, transcript variant X10
doublesex- and mab-3-related transcription factor 1Y-like, transcript variant X14
doublesex- and mab-3-related transcription factor 1Y-like, transcript variant X11
doublesex- and mab-3-related transcription factor 1Y-like, transcript variant X12
doublesex- and mab-3-related transcription factor 1Y-like, transcript variant X7
doublesex- and mab-3-related transcription factor 1Y-like, transcript variant X6
doublesex- and mab-3-related transcription factor 1Y-like, transcript variant X2
doublesex- and mab-3-related transcription factor 1Y-like, transcript variant X13
doublesex- and mab-3-related transcription factor 1Y-like, transcript variant X5
doublesex- and mab-3-related transcription factor 1Y-like, transcript variant X3
doublesex- and mab-3-related transcription factor 1Y-like, transcript variant X1
doublesex- and mab-3-related transcription factor 1Y-like, transcript variant X4
doublesex- and mab-3-related transcription factor 1Y-like, transcript variant X9
doublesex- and mab-3-related transcription factor DM-W-like isoform X2
doublesex- and mab-3-related transcription factor A2-like isoform X1
doublesex- and mab-3-related transcription factor 1Y-like, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
doublesex- and mab-3-related transcription factor 1Y-like isoform X3
uncharacterized LOC122567756, transcript variant X3
uncharacterized LOC122567756, transcript variant X1
uncharacterized LOC122567756, transcript variant X2
homeobox protein prospero-like, transcript variant X1
homeobox protein prospero-like, transcript variant X2
homeobox protein prospero-like isoform X2
homeobox protein prospero-like isoform X1
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 383 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
C-1-tetrahydrofolate synthase, cytoplasmic isoform X1
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 381 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
C-1-tetrahydrofolate synthase, cytoplasmic isoform X2
probable methyltransferase-like protein 15 homolog
dnaJ homolog subfamily C member 13, transcript variant X2
dnaJ homolog subfamily C member 13, transcript variant X1
dnaJ homolog subfamily C member 13 isoform X2
dnaJ homolog subfamily C member 13 isoform X1
angiogenic factor with G patch and FHA domains 1, transcript variant X4
angiogenic factor with G patch and FHA domains 1, transcript variant X5
angiogenic factor with G patch and FHA domains 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
angiogenic factor with G patch and FHA domains 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
angiogenic factor with G patch and FHA domains 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
angiogenic factor with G patch and FHA domains 1 isoform X2
angiogenic factor with G patch and FHA domains 1 isoform X3
angiogenic factor with G patch and FHA domains 1 isoform X1
uncharacterized LOC122567626, transcript variant X2
uncharacterized LOC122567626, transcript variant X3
uncharacterized LOC122567626, transcript variant X1
uncharacterized LOC122567626, transcript variant X4
uncharacterized LOC122567626, transcript variant X6
uncharacterized LOC122567626, transcript variant X5
uncharacterized LOC122567626, transcript variant X7
uncharacterized protein LOC122567626 isoform X1
uncharacterized protein LOC122567626 isoform X2
uncharacterized protein LOC122567626 isoform X3
uncharacterized LOC122567626, transcript variant X8
uncharacterized protein LOC122567626 isoform X4
uncharacterized LOC122567645, transcript variant X2
uncharacterized LOC122567645, transcript variant X1
peptidyl-prolyl cis-trans isomerase FKBP62-like
protein yippee-like 1, transcript variant X13
protein yippee-like 1, transcript variant X14
protein yippee-like 1, transcript variant X17
protein yippee-like 1, transcript variant X15
protein yippee-like 1, transcript variant X16
protein yippee-like 1, transcript variant X1
protein yippee-like 1, transcript variant X7
protein yippee-like 1, transcript variant X10
protein yippee-like 1, transcript variant X9
protein yippee-like 1, transcript variant X11
protein yippee-like 1, transcript variant X5
protein yippee-like 1, transcript variant X4
protein yippee-like 1, transcript variant X3
protein yippee-like 1, transcript variant X6
protein yippee-like 1, transcript variant X8
protein yippee-like 1, transcript variant X2
protein yippee-like 1, transcript variant X12
uncharacterized LOC122567637, transcript variant X2
uncharacterized protein LOC122567637 isoform X2
uncharacterized LOC122567637, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC122567637 isoform X1
SPRY domain-containing SOCS box protein 3-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: SPRY domain-containing SOCS box protein 3-like
cytochrome c oxidase subunit 5A, mitochondrial
DNA-binding protein P3A2, transcript variant X2
DNA-binding protein P3A2, transcript variant X3
DNA-binding protein P3A2, transcript variant X4
DNA-binding protein P3A2, transcript variant X1
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X1
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X2
5-demethoxyubiquinone hydroxylase, mitochondrial
putative uncharacterized protein DDB_G0275629
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122567382, transcript variant X1
uncharacterized LOC122567382, transcript variant X2
scm-like with four MBT domains protein 1, transcript variant X2
scm-like with four MBT domains protein 1, transcript variant X1
scm-like with four MBT domains protein 1, transcript variant X3
scm-like with four MBT domains protein 1 isoform X2
scm-like with four MBT domains protein 1 isoform X1
scm-like with four MBT domains protein 1 isoform X3
peptide chain release factor 1, transcript variant X2
peptide chain release factor 1, transcript variant X1
peptide chain release factor 1 isoform X1
peptide chain release factor 1 isoform X2
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X4
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X3
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X2
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X1
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X4
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X3
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X2
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X1
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X6
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X7
protein rolling stone-like, transcript variant X2
protein rolling stone-like, transcript variant X1
protein rolling stone-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
short stature homeobox protein 2-like, transcript variant X1
short stature homeobox protein 2-like, transcript variant X2
short stature homeobox protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
short stature homeobox protein 2-like isoform X1
short stature homeobox protein 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
F-box/WD repeat-containing protein 9-like, transcript variant X2
F-box/WD repeat-containing protein 9-like, transcript variant X1
F-box/WD repeat-containing protein 9-like
solute carrier family 52, riboflavin transporter, member 3-A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122568014, transcript variant X4
uncharacterized LOC122568014, transcript variant X2
uncharacterized LOC122568014, transcript variant X3
uncharacterized LOC122568014, transcript variant X1
uncharacterized LOC122568014, transcript variant X5
outer dynein arm-docking complex subunit 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
outer dynein arm-docking complex subunit 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
outer dynein arm-docking complex subunit 4-like isoform X2
outer dynein arm-docking complex subunit 4-like isoform X1
outer dynein arm-docking complex subunit 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 43% coverage of the annotated genomic feature by RNAseq alignments
similar to RNA sequence (same species):INSD:GGGP01031690.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 231 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 231 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
solute carrier family 12 member 4, transcript variant X1
solute carrier family 12 member 4, transcript variant X2
solute carrier family 12 member 4, transcript variant X6
solute carrier family 12 member 4, transcript variant X4
solute carrier family 12 member 4, transcript variant X3
solute carrier family 12 member 4, transcript variant X5
solute carrier family 12 member 4 isoform X1
solute carrier family 12 member 4 isoform X3
solute carrier family 12 member 4 isoform X2
solute carrier family 12 member 4 isoform X4
solute carrier family 12 member 4 isoform X5
solute carrier family 12 member 4 isoform X6
solute carrier family 12 member 4, transcript variant X8
solute carrier family 12 member 4, transcript variant X10
solute carrier family 12 member 4, transcript variant X9
solute carrier family 12 member 4 isoform X8
solute carrier family 12 member 4, transcript variant X7
solute carrier family 12 member 4 isoform X7
PRKC apoptosis WT1 regulator protein-like, transcript variant X8
PRKC apoptosis WT1 regulator protein-like, transcript variant X7
PRKC apoptosis WT1 regulator protein-like, transcript variant X5
PRKC apoptosis WT1 regulator protein-like, transcript variant X4
PRKC apoptosis WT1 regulator protein-like, transcript variant X6
PRKC apoptosis WT1 regulator protein-like, transcript variant X9
PRKC apoptosis WT1 regulator protein-like, transcript variant X1
PRKC apoptosis WT1 regulator protein-like, transcript variant X2
PRKC apoptosis WT1 regulator protein-like, transcript variant X3
PRKC apoptosis WT1 regulator protein-like isoform X1
PRKC apoptosis WT1 regulator protein-like isoform X3
PRKC apoptosis WT1 regulator protein-like isoform X2
PRKC apoptosis WT1 regulator protein-like isoform X4
PRKC apoptosis WT1 regulator protein-like isoform X7
PRKC apoptosis WT1 regulator protein-like isoform X5
PRKC apoptosis WT1 regulator protein-like isoform X6
dual specificity protein phosphatase 10-like, transcript variant X2
dual specificity protein phosphatase 10-like, transcript variant X1
dual specificity protein phosphatase 10-like, transcript variant X5
dual specificity protein phosphatase 10-like, transcript variant X6
dual specificity protein phosphatase 10-like, transcript variant X3
dual specificity protein phosphatase 10-like, transcript variant X4
dual specificity protein phosphatase 10-like isoform X2
dual specificity protein phosphatase 10-like isoform X1
dual specificity protein phosphatase 10-like isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein unc-79 homolog
tyrosine-protein phosphatase non-receptor type 14, transcript variant X1
tyrosine-protein phosphatase non-receptor type 14 isoform X1
tyrosine-protein phosphatase non-receptor type 14, transcript variant X5
tyrosine-protein phosphatase non-receptor type 14, transcript variant X2
tyrosine-protein phosphatase non-receptor type 14, transcript variant X3
tyrosine-protein phosphatase non-receptor type 14, transcript variant X4
tyrosine-protein phosphatase non-receptor type 14 isoform X2
uncharacterized LOC122567917, transcript variant X1
uncharacterized LOC122567917, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122567917, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC122567917 isoform X1
uncharacterized LOC122567917, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC122567917 isoform X2
lysM and putative peptidoglycan-binding domain-containing protein 3
uncharacterized LOC122567918, transcript variant X6
uncharacterized LOC122567918, transcript variant X8
uncharacterized LOC122567918, transcript variant X3
uncharacterized LOC122567918, transcript variant X7
uncharacterized LOC122567918, transcript variant X2
uncharacterized LOC122567918, transcript variant X5
uncharacterized LOC122567918, transcript variant X4
uncharacterized LOC122567918, transcript variant X1
uncharacterized protein LOC122567918 isoform X4
uncharacterized protein LOC122567918 isoform X6
uncharacterized protein LOC122567918 isoform X3
uncharacterized protein LOC122567918 isoform X2
uncharacterized protein LOC122567918 isoform X1
uncharacterized protein LOC122567918 isoform X5
monocarboxylate transporter 12-B, transcript variant X1
monocarboxylate transporter 12-B, transcript variant X7
monocarboxylate transporter 12-B, transcript variant X3
monocarboxylate transporter 12-B, transcript variant X4
monocarboxylate transporter 12-B, transcript variant X2
monocarboxylate transporter 12-B, transcript variant X8
monocarboxylate transporter 12-B, transcript variant X6
monocarboxylate transporter 12-B, transcript variant X5
monocarboxylate transporter 12-B, transcript variant X9
monocarboxylate transporter 12-B isoform X1
monocarboxylate transporter 12-B isoform X2
monocarboxylate transporter 12-B isoform X3
monocarboxylate transporter 12-B isoform X4
monocarboxylate transporter 3, transcript variant X2
monocarboxylate transporter 3, transcript variant X1
monocarboxylate transporter 3, transcript variant X6
monocarboxylate transporter 3, transcript variant X4
monocarboxylate transporter 3, transcript variant X5
monocarboxylate transporter 3, transcript variant X7
monocarboxylate transporter 3, transcript variant X3
monocarboxylate transporter 3 isoform X1
monocarboxylate transporter 3 isoform X5
monocarboxylate transporter 3 isoform X3
monocarboxylate transporter 3 isoform X4
monocarboxylate transporter 3 isoform X2
uncharacterized protein LOC122567848 isoform X6
heat shock factor 2-binding protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
heat shock factor 2-binding protein-like, transcript variant X2
heat shock factor 2-binding protein-like
delta(14)-sterol reductase LBR, transcript variant X1
delta(14)-sterol reductase LBR, transcript variant X2
delta(14)-sterol reductase LBR isoform X1
delta(14)-sterol reductase LBR isoform X2
proteasome assembly chaperone 1, transcript variant X2
proteasome assembly chaperone 1, transcript variant X1
proteasome assembly chaperone 1 isoform X1
proteasome assembly chaperone 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ribosomal protein S6 kinase 2 beta, transcript variant X3
ribosomal protein S6 kinase 2 beta, transcript variant X1
ribosomal protein S6 kinase 2 beta, transcript variant X2
ribosomal protein S6 kinase 2 beta isoform X1
ribosomal protein S6 kinase 2 beta isoform X2
uncharacterized LOC122567854, transcript variant X1
uncharacterized LOC122567854, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 44% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
G-protein coupled receptor dmsr-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
G-protein coupled receptor dmsr-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Bardet-Biedl syndrome 4 protein homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Bardet-Biedl syndrome 4 protein homolog, transcript variant X1
Bardet-Biedl syndrome 4 protein homolog isoform X1
Bardet-Biedl syndrome 4 protein homolog isoform X2
solute carrier family 35 member F5, transcript variant X1
solute carrier family 35 member F5 isoform X1
solute carrier family 35 member F5, transcript variant X2
solute carrier family 35 member F5 isoform X2
putative uncharacterized protein DDB_G0282133, transcript variant X1
putative uncharacterized protein DDB_G0282133, transcript variant X2
putative uncharacterized protein DDB_G0282133, transcript variant X4
putative uncharacterized protein DDB_G0282133, transcript variant X3
uncharacterized protein LOC122567898 isoform X1
uncharacterized protein LOC122567898 isoform X2
uncharacterized protein LOC122567898 isoform X4
uncharacterized protein LOC122567898 isoform X3
putative uncharacterized protein DDB_G0282133, transcript variant X7
putative uncharacterized protein DDB_G0282133, transcript variant X6
putative uncharacterized protein DDB_G0282133, transcript variant X5
putative uncharacterized protein DDB_G0282133 isoform X5
putative uncharacterized protein DDB_G0282133 isoform X6
inosine-5'-monophosphate dehydrogenase 1b-like
eukaryotic translation elongation factor 1 epsilon-1
ADP-ribosylation factor-like protein 6-interacting protein 6
mitochondrial uncoupling protein Bmcp, transcript variant X6
mitochondrial uncoupling protein Bmcp, transcript variant X7
mitochondrial uncoupling protein Bmcp, transcript variant X4
mitochondrial uncoupling protein Bmcp, transcript variant X3
mitochondrial uncoupling protein Bmcp, transcript variant X5
mitochondrial uncoupling protein Bmcp, transcript variant X2
mitochondrial uncoupling protein Bmcp, transcript variant X1
mitochondrial uncoupling protein Bmcp isoform X2
mitochondrial uncoupling protein Bmcp isoform X1
uncharacterized LOC122567338, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122567338, transcript variant X4
uncharacterized LOC122567338, transcript variant X3
uncharacterized protein LOC122567338 isoform X4
uncharacterized LOC122567338, transcript variant X1
uncharacterized LOC122567338, transcript variant X2
uncharacterized protein LOC122567338 isoform X1
uncharacterized protein LOC122567338 isoform X2
uncharacterized protein LOC122567338 isoform X3
N-acylneuraminate-9-phosphatase, transcript variant X2
N-acylneuraminate-9-phosphatase, transcript variant X1
neurochondrin homolog, transcript variant X1
neurochondrin homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
steroid hormone receptor ERR1, transcript variant X2
steroid hormone receptor ERR1 isoform X2
steroid hormone receptor ERR1, transcript variant X1
steroid hormone receptor ERR1, transcript variant X5
steroid hormone receptor ERR1, transcript variant X3
steroid hormone receptor ERR1, transcript variant X6
steroid hormone receptor ERR1 isoform X1
steroid hormone receptor ERR1 isoform X5
steroid hormone receptor ERR1 isoform X3
steroid hormone receptor ERR1 isoform X6
steroid hormone receptor ERR1, transcript variant X4
steroid hormone receptor ERR1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122567538, transcript variant X2
uncharacterized protein LOC122567538 isoform X2
uncharacterized LOC122567538, transcript variant X1
uncharacterized protein LOC122567538 isoform X1
glucose dehydrogenase [FAD, quinone]-like
synaptogenesis protein syg-2, transcript variant X4
synaptogenesis protein syg-2, transcript variant X6
neural cell adhesion molecule 2 isoform X4
synaptogenesis protein syg-2, transcript variant X5
neural cell adhesion molecule 2 isoform X5
synaptogenesis protein syg-2, transcript variant X3
synaptogenesis protein syg-2, transcript variant X1
synaptogenesis protein syg-2, transcript variant X2
neural cell adhesion molecule 2 isoform X1
neural cell adhesion molecule 2 isoform X2
neural cell adhesion molecule 2 isoform X3
synaptogenesis protein syg-2, transcript variant X7
aprataxin and PNK-like factor, transcript variant X3
aprataxin and PNK-like factor, transcript variant X4
aprataxin and PNK-like factor, transcript variant X5
aprataxin and PNK-like factor, transcript variant X2
aprataxin and PNK-like factor, transcript variant X1
aprataxin and PNK-like factor isoform X4
aprataxin and PNK-like factor isoform X3
aprataxin and PNK-like factor isoform X5
aprataxin and PNK-like factor isoform X2
aprataxin and PNK-like factor isoform X1
WD repeat-containing protein 20, transcript variant X2
WD repeat-containing protein 20, transcript variant X3
WD repeat-containing protein 20, transcript variant X1
WD repeat-containing protein 20, transcript variant X4
WD repeat-containing protein 20, transcript variant X5
WD repeat-containing protein 20 isoform X2
WD repeat-containing protein 20 isoform X1
U3 small nucleolar RNA-associated protein 25 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 192, transcript variant X1
transmembrane protein 192, transcript variant X2
transmembrane protein 192, transcript variant X3
uncharacterized LOC122567915, transcript variant X1
uncharacterized LOC122567915, transcript variant X2
uncharacterized protein LOC122567915 isoform X2
uncharacterized protein LOC122567915 isoform X1
golgin subfamily A member 6-like protein 22, transcript variant X4
golgin subfamily A member 6-like protein 22, transcript variant X3
golgin subfamily A member 6-like protein 22, transcript variant X2
golgin subfamily A member 6-like protein 22, transcript variant X1
golgin subfamily A member 6-like protein 22 isoform X3
golgin subfamily A member 6-like protein 22 isoform X2
probable serine/threonine-protein kinase kinX isoform X1
ataxin-7-like protein 3, transcript variant X2
ataxin-7-like protein 3, transcript variant X1
ataxin-7-like protein 3, transcript variant X3
replication stress response regulator SDE2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC122567872
protein FAM161A-like, transcript variant X1
protein FAM161A-like, transcript variant X2
ubiquinone biosynthesis monooxygenase COQ6, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ubiquinone biosynthesis monooxygenase COQ6, mitochondrial, transcript variant X1
ubiquinone biosynthesis monooxygenase COQ6, mitochondrial isoform X1
ubiquinone biosynthesis monooxygenase COQ6, mitochondrial, transcript variant X3
ubiquinone biosynthesis monooxygenase COQ6, mitochondrial isoform X2
transient receptor potential channel pyrexia, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transient receptor potential channel pyrexia, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transient receptor potential channel pyrexia isoform X2
transient receptor potential channel pyrexia isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
conserved oligomeric Golgi complex subunit 4
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X1
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X2
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X5
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X4
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X3
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X7
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X6
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X9
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X10
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X8
broad-complex core protein isoforms 1/2/3/4/5-like isoform X9
broad-complex core protein isoforms 1/2/3/4/5-like isoform X5
broad-complex core protein isoforms 1/2/3/4/5-like isoform X7
broad-complex core protein isoforms 1/2/3/4/5-like isoform X4
broad-complex core protein isoforms 1/2/3/4/5-like isoform X1
broad-complex core protein isoforms 1/2/3/4/5-like isoform X2
broad-complex core protein isoforms 1/2/3/4/5-like isoform X8
broad-complex core protein isoforms 1/2/3/4/5-like isoform X3
broad-complex core protein isoforms 1/2/3/4/5-like isoform X6
transcription and mRNA export factor ENY2
mitochondrial import inner membrane translocase subunit Tim21, transcript variant X8
mitochondrial import inner membrane translocase subunit Tim21, transcript variant X3
mitochondrial import inner membrane translocase subunit Tim21, transcript variant X2
mitochondrial import inner membrane translocase subunit Tim21, transcript variant X6
mitochondrial import inner membrane translocase subunit Tim21, transcript variant X5
mitochondrial import inner membrane translocase subunit Tim21, transcript variant X7
mitochondrial import inner membrane translocase subunit Tim21, transcript variant X4
mitochondrial import inner membrane translocase subunit Tim21, transcript variant X1
mitochondrial import inner membrane translocase subunit Tim21
T-box transcription factor TBX20-like, transcript variant X1
T-box transcription factor TBX20-like isoform X1
T-box transcription factor TBX20-like, transcript variant X2
T-box transcription factor TBX20-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
T-box protein H15-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
T-box protein H15-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
WD repeat and FYVE domain-containing protein 2
suppressor of hairless protein, transcript variant X2
suppressor of hairless protein, transcript variant X1
DNA excision repair protein ERCC-5, transcript variant X2
DNA excision repair protein ERCC-5, transcript variant X3
DNA excision repair protein ERCC-5, transcript variant X1
DNA excision repair protein ERCC-5, transcript variant X4
glutathione hydrolase 1 proenzyme-like, transcript variant X2
glutathione hydrolase 1 proenzyme-like, transcript variant X3
glutathione hydrolase 1 proenzyme-like, transcript variant X1
glutathione hydrolase 1 proenzyme-like isoform X2
glutathione hydrolase 1 proenzyme-like isoform X1
glutathione hydrolase 1 proenzyme-like isoform X3
cyclin-dependent kinase 8, transcript variant X1
cyclin-dependent kinase 8, transcript variant X2
cyclin-dependent kinase 8, transcript variant X3
uncharacterized LOC122567722, transcript variant X1
uncharacterized LOC122567722, transcript variant X2
uncharacterized protein LOC122567722 isoform X1
uncharacterized protein LOC122567722 isoform X2
ecdysone 20-monooxygenase, transcript variant X1
ecdysone 20-monooxygenase, transcript variant X2
ecdysone 20-monooxygenase, transcript variant X3
adenosine 3'-phospho 5'-phosphosulfate transporter 1
deoxynucleoside kinase, transcript variant X2
deoxynucleoside kinase, transcript variant X1
uncharacterized LOC122567736, transcript variant X1
uncharacterized LOC122567736, transcript variant X2
uncharacterized protein LOC122567724 isoform X3
zinc finger protein 608-like, transcript variant X8
zinc finger protein 608-like, transcript variant X4
zinc finger protein 608-like, transcript variant X2
zinc finger protein 608-like, transcript variant X3
zinc finger protein 608-like, transcript variant X1
zinc finger protein 608-like, transcript variant X7
zinc finger protein 608-like, transcript variant X5
zinc finger protein 608-like, transcript variant X6
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5
transcriptional regulator ATRX-like, transcript variant X1
transcriptional regulator ATRX-like, transcript variant X2
uncharacterized protein LOC122567723 isoform X1
transcriptional regulator ATRX-like isoform X2
kinesin-like protein KIF2A, transcript variant X1
kinesin-like protein KIF2A, transcript variant X2
kinesin-like protein KIF2A, transcript variant X5
kinesin-like protein KIF2A, transcript variant X6
kinesin-like protein KIF2A, transcript variant X4
kinesin-like protein KIF2A, transcript variant X9
kinesin-like protein KIF2A, transcript variant X7
kinesin-like protein KIF2A, transcript variant X8
kinesin-like protein KIF2A, transcript variant X10
kinesin-like protein KIF2A, transcript variant X3
hybrid signal transduction histidine kinase B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins
EH domain-containing protein 3, transcript variant X3
EH domain-containing protein 3, transcript variant X2
EH domain-containing protein 3, transcript variant X1
zinc finger protein 25-like, transcript variant X5
zinc finger protein 25-like, transcript variant X4
zinc finger protein 25-like, transcript variant X3
zinc finger protein 25-like, transcript variant X2
zinc finger protein 25-like, transcript variant X1
zinc finger protein 25-like, transcript variant X6
uncharacterized protein C14orf119, transcript variant X2
signal recognition particle 14 kDa protein, transcript variant X2
signal recognition particle 14 kDa protein, transcript variant X1
signal recognition particle 14 kDa protein
uncharacterized protein C14orf119, transcript variant X1
uncharacterized protein C14orf119, transcript variant X3
uncharacterized LOC122567770, transcript variant X2
uncharacterized LOC122567770, transcript variant X1
uncharacterized protein LOC122567770 isoform X1
uncharacterized LOC122567770, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC122567770 isoform X2
proteasome activator complex subunit 4-like, transcript variant X1
proteasome activator complex subunit 4-like isoform X1
proteasome activator complex subunit 4-like, transcript variant X2
proteasome activator complex subunit 4-like isoform X2
flavin reductase (NADPH), transcript variant X2
flavin reductase (NADPH), transcript variant X1
N-alpha-acetyltransferase 80, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
N-alpha-acetyltransferase 80, transcript variant X1
mediator of RNA polymerase II transcription subunit 6, transcript variant X3
mediator of RNA polymerase II transcription subunit 6, transcript variant X1
mediator of RNA polymerase II transcription subunit 6, transcript variant X2
mediator of RNA polymerase II transcription subunit 6 isoform X1
mediator of RNA polymerase II transcription subunit 6 isoform X2
mediator of RNA polymerase II transcription subunit 6 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 68% coverage of the annotated genomic feature by RNAseq alignments
F-box only protein 11, transcript variant X8
F-box only protein 11, transcript variant X6
F-box only protein 11, transcript variant X5
F-box only protein 11, transcript variant X3
F-box only protein 11, transcript variant X2
F-box only protein 11, transcript variant X4
F-box only protein 11, transcript variant X7
F-box only protein 11, transcript variant X1
SH3KBP1-binding protein 1, transcript variant X2
SH3KBP1-binding protein 1, transcript variant X1
odorant receptor 13a-like, transcript variant X1
odorant receptor 13a-like, transcript variant X2
odorant receptor 13a-like, transcript variant X3
L-threonine ammonia-lyase, transcript variant X2
L-threonine ammonia-lyase, transcript variant X1
uncharacterized LOC122567424, transcript variant X1
uncharacterized LOC122567424, transcript variant X6
uncharacterized LOC122567424, transcript variant X2
uncharacterized LOC122567424, transcript variant X3
uncharacterized LOC122567424, transcript variant X4
uncharacterized LOC122567424, transcript variant X5
tubulin--tyrosine ligase-like protein 12, transcript variant X1
tubulin--tyrosine ligase-like protein 12, transcript variant X2
tubulin--tyrosine ligase-like protein 12
RNA-binding protein 34-like, transcript variant X2
RNA-binding protein 34-like, transcript variant X1
cysteine-rich DPF motif domain-containing protein 1, transcript variant X1
cysteine-rich DPF motif domain-containing protein 1, transcript variant X2
cysteine-rich DPF motif domain-containing protein 1
putative transferase CAF17 homolog, mitochondrial, transcript variant X2
putative transferase CAF17 homolog, mitochondrial, transcript variant X1
putative transferase CAF17 homolog, mitochondrial
testis-specific serine/threonine-protein kinase 1, transcript variant X2
testis-specific serine/threonine-protein kinase 1, transcript variant X1
testis-specific serine/threonine-protein kinase 1, transcript variant X3
testis-specific serine/threonine-protein kinase 2 isoform X1
testis-specific serine/threonine-protein kinase 1 isoform X2
zinc transporter 7, transcript variant X1
zinc transporter 7, transcript variant X2
zinc transporter 7, transcript variant X3
uncharacterized LOC122567787, transcript variant X5
uncharacterized LOC122567787, transcript variant X6
uncharacterized LOC122567787, transcript variant X1
uncharacterized LOC122567787, transcript variant X3
uncharacterized LOC122567787, transcript variant X4
uncharacterized LOC122567787, transcript variant X2
uncharacterized protein LOC122567787 isoform X2
uncharacterized protein LOC122567787 isoform X1
LOW QUALITY PROTEIN: neuroendocrine convertase 2-like
uncharacterized LOC122567799, transcript variant X1
uncharacterized protein LOC122567799 isoform X1
uncharacterized LOC122567799, transcript variant X2
uncharacterized protein LOC122567799 isoform X2
myb-like protein V, transcript variant X2
myb-like protein V, transcript variant X1
myb-like protein V, transcript variant X3
protein FAM50 homolog, transcript variant X2
protein FAM50 homolog, transcript variant X1
G protein pathway suppressor 2, transcript variant X1
G protein pathway suppressor 2, transcript variant X2
G protein pathway suppressor 2, transcript variant X3
G protein pathway suppressor 2 isoform X2
YLP motif-containing protein 1 isoform X3
protein O-mannosyl-transferase 2, transcript variant X4
probable ATP-dependent RNA helicase spindle-E, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable ATP-dependent RNA helicase spindle-E, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
probable ATP-dependent RNA helicase spindle-E
protein O-mannosyl-transferase 2, transcript variant X2
protein O-mannosyl-transferase 2, transcript variant X1
protein O-mannosyl-transferase 2, transcript variant X3
transmembrane protein 8B, transcript variant X6
transmembrane protein 8B, transcript variant X1
transmembrane protein 8B, transcript variant X2
transmembrane protein 8B, transcript variant X5
transmembrane protein 8B, transcript variant X3
transmembrane protein 8B, transcript variant X4
transmembrane protein 8B, transcript variant X7
L-asparaginase-like, transcript variant X5
L-asparaginase-like, transcript variant X1
L-asparaginase-like, transcript variant X4
L-asparaginase-like, transcript variant X3
L-asparaginase-like, transcript variant X2
L-asparaginase-like, transcript variant X6
putative zinc finger protein 735, transcript variant X3
uncharacterized LOC122567813, transcript variant X2
uncharacterized LOC122567813, transcript variant X1
uncharacterized LOC122567813, transcript variant X4
uncharacterized LOC122567813, transcript variant X3
uncharacterized protein LOC122567813 isoform X1
uncharacterized protein LOC122567813 isoform X2
putative zinc finger protein 735, transcript variant X2
putative zinc finger protein 735, transcript variant X5
putative zinc finger protein 735, transcript variant X1
putative zinc finger protein 286B isoform X1
putative zinc finger protein 735, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
putative zinc finger protein 735, transcript variant X4
zinc finger protein Xfin-like isoform X5
putative zinc finger protein 735 isoform X3
tubulin polyglutamylase TTLL5, transcript variant X2
tubulin polyglutamylase TTLL5, transcript variant X5
tubulin polyglutamylase TTLL5, transcript variant X1
tubulin polyglutamylase TTLL5, transcript variant X4
tubulin polyglutamylase TTLL5, transcript variant X3
tubulin polyglutamylase TTLL5, transcript variant X6
tubulin polyglutamylase TTLL5 isoform X3
tubulin polyglutamylase TTLL5 isoform X2
tubulin polyglutamylase TTLL5 isoform X1
tubulin polyglutamylase TTLL5 isoform X4
uncharacterized LOC122567802, transcript variant X1
uncharacterized LOC122567802, transcript variant X2
molybdopterin synthase catalytic subunit, transcript variant X1
molybdopterin synthase catalytic subunit, transcript variant X2
molybdopterin synthase catalytic subunit
RNA-binding protein Nova-1, transcript variant X4
RNA-binding protein Nova-1, transcript variant X5
RNA-binding protein Nova-1, transcript variant X1
RNA-binding protein Nova-1, transcript variant X3
RNA-binding protein Nova-1, transcript variant X2
scaffold protein salvador-like, transcript variant X3
scaffold protein salvador-like, transcript variant X2
scaffold protein salvador-like, transcript variant X1
scaffold protein salvador-like isoform X2
scaffold protein salvador-like isoform X1
protein salvador homolog 1-like isoform X3
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform-like, transcript variant X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform-like, transcript variant X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform-like isoform X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform-like isoform X2
uncharacterized LOC122567752, transcript variant X1
uncharacterized LOC122567752, transcript variant X4
uncharacterized LOC122567752, transcript variant X9
uncharacterized LOC122567752, transcript variant X5
uncharacterized LOC122567752, transcript variant X7
uncharacterized LOC122567752, transcript variant X3
uncharacterized LOC122567752, transcript variant X8
uncharacterized LOC122567752, transcript variant X6
uncharacterized LOC122567752, transcript variant X2
neutral and basic amino acid transport protein rBAT
sodium/calcium exchanger 3, transcript variant X3
sodium/calcium exchanger 3, transcript variant X2
sodium/calcium exchanger 3, transcript variant X1
sodium/calcium exchanger 3, transcript variant X4
sodium/calcium exchanger 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine-rich repeat-containing protein 15-like, transcript variant X2
leucine-rich repeat-containing protein 15-like, transcript variant X1
leucine-rich repeat-containing protein 15-like
leucine-rich repeat-containing G-protein coupled receptor 4-like
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X6
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X4
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X3
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X1
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X5
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X2
insulin-like growth factor-binding protein complex acid labile subunit isoform X1
insulin-like growth factor-binding protein complex acid labile subunit isoform X2
polyribonucleotide nucleotidyltransferase 1, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
complex I intermediate-associated protein 30, mitochondrial
probable cardiolipin synthase (CMP-forming)
pre-mRNA-splicing factor ISY1 homolog, transcript variant X1
pre-mRNA-splicing factor ISY1 homolog, transcript variant X2
probable phospholipid hydroperoxide glutathione peroxidase
putative epidermal cell surface receptor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122567423, transcript variant X3
uncharacterized LOC122567423, transcript variant X2
uncharacterized LOC122567423, transcript variant X1
uncharacterized protein LOC122567423 isoform X3
uncharacterized protein LOC122567423 isoform X2
uncharacterized protein LOC122567423 isoform X1
baculoviral IAP repeat-containing protein 6, transcript variant X1
baculoviral IAP repeat-containing protein 6, transcript variant X2
baculoviral IAP repeat-containing protein 6 isoform X2
baculoviral IAP repeat-containing protein 6 isoform X1
39S ribosomal protein L11, mitochondrial
RING-type E3 ubiquitin-protein ligase PPIL2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
RING-type E3 ubiquitin-protein ligase PPIL2, transcript variant X1
RING-type E3 ubiquitin-protein ligase PPIL2
uncharacterized LOC122567895, transcript variant X3
uncharacterized LOC122567895, transcript variant X2
uncharacterized LOC122567895, transcript variant X4
uncharacterized LOC122567895, transcript variant X1
LOW QUALITY PROTEIN: uncharacterized protein LOC122567894
centrosomal and chromosomal factor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
centrosomal and chromosomal factor-like, transcript variant X1
ribonuclease P protein subunit p14, transcript variant X2
ribonuclease P protein subunit p14, transcript variant X1
mitochondrial intermembrane space import and assembly protein 40-B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
synaptosomal-associated protein 25, transcript variant X5
synaptosomal-associated protein 25, transcript variant X11
synaptosomal-associated protein 25, transcript variant X4
synaptosomal-associated protein 25, transcript variant X6
synaptosomal-associated protein 25, transcript variant X1
synaptosomal-associated protein 25, transcript variant X2
synaptosomal-associated protein 25, transcript variant X7
synaptosomal-associated protein 25, transcript variant X10
synaptosomal-associated protein 25, transcript variant X9
synaptosomal-associated protein 25 isoform X4
synaptosomal-associated protein 25 isoform X1
synaptosomal-associated protein 25 isoform X2
synaptosomal-associated protein 25 isoform X8
synaptosomal-associated protein 25 isoform X7
synaptosomal-associated protein 25 isoform X6
synaptosomal-associated protein 25, transcript variant X8
synaptosomal-associated protein 25, transcript variant X3
synaptosomal-associated protein 25 isoform X5
synaptosomal-associated protein 25 isoform X3
pre-mRNA-processing factor 39, transcript variant X2
pre-mRNA-processing factor 39, transcript variant X1
pre-mRNA-processing factor 39 isoform X2
pre-mRNA-processing factor 39 isoform X1
uncharacterized LOC122567658, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122567658, transcript variant X2
uncharacterized LOC122567658, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122567658, transcript variant X4
uncharacterized protein LOC122567658 isoform X1
uncharacterized protein LOC122567658 isoform X2
zinc finger protein 91, transcript variant X2
zinc finger protein 91, transcript variant X4
zinc finger protein 91, transcript variant X1
zinc finger protein 91, transcript variant X3
ester hydrolase C11orf54 homolog, transcript variant X2
ester hydrolase C11orf54 homolog, transcript variant X1
receptor-type guanylate cyclase daf-11, transcript variant X4
receptor-type guanylate cyclase daf-11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
receptor-type guanylate cyclase daf-11, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
receptor-type guanylate cyclase daf-11 isoform X3
receptor-type guanylate cyclase daf-11, transcript variant X1
receptor-type guanylate cyclase daf-11 isoform X1
receptor-type guanylate cyclase daf-11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
receptor-type guanylate cyclase daf-11 isoform X2
receptor-type guanylate cyclase daf-11, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
receptor-type guanylate cyclase daf-11 isoform X4
ankyrin repeat and zinc finger domain-containing protein 1-like, transcript variant X2
ankyrin repeat and zinc finger domain-containing protein 1-like, transcript variant X1
ankyrin repeat and zinc finger domain-containing protein 1-like, transcript variant X3
ankyrin repeat and zinc finger domain-containing protein 1-like isoform X2
ankyrin repeat and zinc finger domain-containing protein 1-like isoform X1
ankyrin repeat and zinc finger domain-containing protein 1-like isoform X3
kinesin-like protein KIF21A, transcript variant X2
kinesin-like protein KIF21A, transcript variant X1
bifunctional arginine demethylase and lysyl-hydroxylase PSR
histone-lysine N-methyltransferase, H3 lysine-79 specific, transcript variant X1
histone-lysine N-methyltransferase, H3 lysine-79 specific, transcript variant X4
histone-lysine N-methyltransferase, H3 lysine-79 specific, transcript variant X2
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X1
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X2
histone-lysine N-methyltransferase, H3 lysine-79 specific, transcript variant X3
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X3
A disintegrin and metalloproteinase with thrombospondin motifs 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
cilia- and flagella-associated protein 57, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cilia- and flagella-associated protein 57, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cilia- and flagella-associated protein 57
40S ribosomal protein S29, transcript variant X1
40S ribosomal protein S29, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 20, transcript variant X1
mediator of RNA polymerase II transcription subunit 20, transcript variant X2
mediator of RNA polymerase II transcription subunit 20, transcript variant X3
mediator of RNA polymerase II transcription subunit 20 isoform X1
mediator of RNA polymerase II transcription subunit 20 isoform X2
facilitated trehalose transporter Tret1-2 homolog, transcript variant X1
facilitated trehalose transporter Tret1-2 homolog isoform X1
facilitated trehalose transporter Tret1-2 homolog, transcript variant X2
facilitated trehalose transporter Tret1-2 homolog isoform X2
dystroglycan-like, transcript variant X3
dystroglycan-like, transcript variant X1
dystroglycan-like, transcript variant X2
dystroglycan-like, transcript variant X6
dystroglycan-like, transcript variant X5
dystroglycan-like, transcript variant X4
uncharacterized LOC122567706, transcript variant X2
uncharacterized LOC122567706, transcript variant X1
feline leukemia virus subgroup C receptor-related protein 2-like, transcript variant X1
feline leukemia virus subgroup C receptor-related protein 2-like, transcript variant X6
feline leukemia virus subgroup C receptor-related protein 2-like, transcript variant X4
feline leukemia virus subgroup C receptor-related protein 2-like, transcript variant X5
feline leukemia virus subgroup C receptor-related protein 2-like, transcript variant X3
feline leukemia virus subgroup C receptor-related protein 2-like, transcript variant X2
feline leukemia virus subgroup C receptor-related protein 2-like, transcript variant X7
feline leukemia virus subgroup C receptor-related protein 2-like isoform X1
feline leukemia virus subgroup C receptor-related protein 2-like isoform X2
uncharacterized LOC122567690, transcript variant X1
uncharacterized LOC122567690, transcript variant X3
uncharacterized protein LOC122567690 isoform X1
uncharacterized protein LOC122567690 isoform X3
uncharacterized LOC122567690, transcript variant X2
uncharacterized protein LOC122567690 isoform X2
uncharacterized LOC122567690, transcript variant X4
uncharacterized protein LOC122567690 isoform X4
uncharacterized LOC122567690, transcript variant X9
uncharacterized LOC122567690, transcript variant X5
uncharacterized LOC122567690, transcript variant X7
uncharacterized LOC122567690, transcript variant X8
uncharacterized LOC122567690, transcript variant X6
uncharacterized protein LOC122567690 isoform X5
uncharacterized protein LOC122567690 isoform X7
uncharacterized protein LOC122567690 isoform X6
probable serine/threonine-protein kinase clkA
queuosine salvage protein, transcript variant X2
queuosine salvage protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein DDB_G0283697, transcript variant X2
uncharacterized protein DDB_G0283697, transcript variant X1
NEDD8-conjugating enzyme UBE2F-like, transcript variant X1
NEDD8-conjugating enzyme UBE2F-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
vacuolar protein-sorting-associated protein 25
excitatory amino acid transporter 1, transcript variant X2
excitatory amino acid transporter 1, transcript variant X1
cyclin-dependent kinases regulatory subunit
exocyst complex component 5, transcript variant X1
exocyst complex component 5, transcript variant X2
protein arginine N-methyltransferase 1, transcript variant X1
protein arginine N-methyltransferase 1, transcript variant X2
protein arginine N-methyltransferase 1 isoform X1
protein arginine N-methyltransferase 1 isoform X2
AT-rich interactive domain-containing protein 4B
uncharacterized LOC122567461, transcript variant X2
uncharacterized LOC122567461, transcript variant X1
uncharacterized LOC122567461, transcript variant X3
ubiquitin carboxyl-terminal hydrolase puf
transmembrane protein 245, transcript variant X1
transmembrane protein 245, transcript variant X2
translation initiation factor IF-2, mitochondrial
proline hydroxylase buaE, transcript variant X2
proline hydroxylase buaE, transcript variant X1
proline hydroxylase buaE, transcript variant X3
uncharacterized LOC122567470, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122567470, transcript variant X2
uncharacterized protein LOC122567470 isoform X1
uncharacterized protein LOC122567470 isoform X2
uncharacterized LOC122567469, transcript variant X1
uncharacterized LOC122567469, transcript variant X3
uncharacterized LOC122567469, transcript variant X2
uncharacterized LOC122567469, transcript variant X8
uncharacterized LOC122567469, transcript variant X5
uncharacterized LOC122567469, transcript variant X7
uncharacterized LOC122567469, transcript variant X6
uncharacterized LOC122567469, transcript variant X10
uncharacterized LOC122567469, transcript variant X9
uncharacterized LOC122567469, transcript variant X4
uncharacterized protein LOC122567469 isoform X1
uncharacterized protein LOC122567469 isoform X2
uncharacterized protein LOC122567469 isoform X3
transcription factor mef2A, transcript variant X1
transcription factor mef2A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
homeobox protein SIX1-like, transcript variant X11
homeobox protein SIX1-like, transcript variant X1
homeobox protein SIX1-like, transcript variant X4
homeobox protein SIX1-like, transcript variant X2
homeobox protein SIX1-like, transcript variant X3
homeobox protein SIX1-like, transcript variant X5
homeobox protein SIX1-like, transcript variant X6
homeobox protein SIX1-like, transcript variant X7
homeobox protein SIX1-like, transcript variant X8
homeobox protein SIX1-like, transcript variant X9
homeobox protein SIX1-like, transcript variant X10
uncharacterized LOC122567835, transcript variant X1
uncharacterized LOC122567835, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
probable Rho GTPase-activating protein CG5521, transcript variant X8
probable Rho GTPase-activating protein CG5521, transcript variant X7
probable Rho GTPase-activating protein CG5521, transcript variant X1
probable Rho GTPase-activating protein CG5521, transcript variant X2
probable Rho GTPase-activating protein CG5521, transcript variant X5
probable Rho GTPase-activating protein CG5521, transcript variant X4
probable Rho GTPase-activating protein CG5521, transcript variant X3
probable Rho GTPase-activating protein CG5521, transcript variant X6
ral GTPase-activating protein subunit alpha-1 isoform X1
ral GTPase-activating protein subunit alpha-1 isoform X2
ral GTPase-activating protein subunit alpha-1 isoform X4
probable Rho GTPase-activating protein CG5521 isoform X7
ral GTPase-activating protein subunit alpha-1 isoform X3
ral GTPase-activating protein subunit alpha-1 isoform X5
ral GTPase-activating protein subunit alpha-1 isoform X6
ral GTPase-activating protein subunit alpha-1 isoform X8
kinesin-like protein Klp98A, transcript variant X2
kinesin-like protein Klp98A, transcript variant X1
myosin-I heavy chain, transcript variant X1
myosin-I heavy chain, transcript variant X2
balbiani ring protein 3, transcript variant X2
balbiani ring protein 3, transcript variant X1
balbiani ring protein 3, transcript variant X5
balbiani ring protein 3, transcript variant X4
balbiani ring protein 3, transcript variant X3
balbiani ring protein 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X2
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X1
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X4
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X5
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X3
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X2
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X1
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X4
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X3
uncharacterized LOC122567615, transcript variant X3
uncharacterized LOC122567615, transcript variant X4
uncharacterized LOC122567615, transcript variant X1
uncharacterized LOC122567615, transcript variant X2
uncharacterized LOC122567613, transcript variant X1
uncharacterized LOC122567613, transcript variant X6
uncharacterized LOC122567613, transcript variant X7
uncharacterized LOC122567613, transcript variant X3
uncharacterized LOC122567613, transcript variant X9
uncharacterized LOC122567613, transcript variant X10
uncharacterized LOC122567613, transcript variant X5
uncharacterized LOC122567613, transcript variant X4
uncharacterized LOC122567613, transcript variant X2
uncharacterized LOC122567613, transcript variant X8
ribosomal RNA processing protein 36 homolog, transcript variant X3
ribosomal RNA processing protein 36 homolog, transcript variant X6
ribosomal RNA processing protein 36 homolog, transcript variant X7
ribosomal RNA processing protein 36 homolog, transcript variant X5
ribosomal RNA processing protein 36 homolog, transcript variant X1
ribosomal RNA processing protein 36 homolog, transcript variant X2
ribosomal RNA processing protein 36 homolog, transcript variant X4
ribosomal RNA processing protein 36 homolog
sodium/potassium-transporting ATPase subunit alpha, transcript variant X6
sodium/potassium-transporting ATPase subunit alpha, transcript variant X2
sodium/potassium-transporting ATPase subunit alpha, transcript variant X1
sodium/potassium-transporting ATPase subunit alpha, transcript variant X3
sodium/potassium-transporting ATPase subunit alpha, transcript variant X7
sodium/potassium-transporting ATPase subunit alpha, transcript variant X4
sodium/potassium-transporting ATPase subunit alpha, transcript variant X8
sodium/potassium-transporting ATPase subunit alpha, transcript variant X5
sodium/potassium-transporting ATPase subunit alpha isoform X6
sodium/potassium-transporting ATPase subunit alpha isoform X2
sodium/potassium-transporting ATPase subunit alpha isoform X1
sodium/potassium-transporting ATPase subunit alpha isoform X3
sodium/potassium-transporting ATPase subunit alpha isoform X7
sodium/potassium-transporting ATPase subunit alpha isoform X4
sodium/potassium-transporting ATPase subunit alpha isoform X8
sodium/potassium-transporting ATPase subunit alpha isoform X5
trigger factor-like, transcript variant X1
trigger factor-like, transcript variant X3
trigger factor-like, transcript variant X2
zinc finger CCCH domain-containing protein 15 homolog isoform X2
NPC intracellular cholesterol transporter 2-like
retinol dehydrogenase 7, transcript variant X2
retinol dehydrogenase 7, transcript variant X3
retinol dehydrogenase 7, transcript variant X1
39S ribosomal protein S18a, mitochondrial
ribosome-releasing factor 2, mitochondrial, transcript variant X2
ribosome-releasing factor 2, mitochondrial, transcript variant X1
ribosome-releasing factor 2, mitochondrial
transcription factor kayak, transcript variant X2
transcription factor kayak, transcript variant X1
transcription factor kayak, transcript variant X3
TLD domain-containing protein 2, transcript variant X11
TLD domain-containing protein 2, transcript variant X13
oxidation resistance protein 1 isoform X9
oxidation resistance protein 1 isoform X11
TLD domain-containing protein 2, transcript variant X9
TLD domain-containing protein 2, transcript variant X8
TLD domain-containing protein 2, transcript variant X7
TLD domain-containing protein 2, transcript variant X10
oxidation resistance protein 1 isoform X7
oxidation resistance protein 1 isoform X8
TLD domain-containing protein 2, transcript variant X1
TLD domain-containing protein 2, transcript variant X3
TLD domain-containing protein 2, transcript variant X5
TLD domain-containing protein 2, transcript variant X4
TLD domain-containing protein 2, transcript variant X6
TLD domain-containing protein 2, transcript variant X2
nuclear receptor coactivator 7 isoform X1
oxidation resistance protein 1 isoform X3
oxidation resistance protein 1 isoform X5
oxidation resistance protein 1 isoform X6
oxidation resistance protein 1 isoform X4
oxidation resistance protein 1 isoform X2
TLD domain-containing protein 2, transcript variant X12
oxidation resistance protein 1 isoform X10
TLD domain-containing protein 2, transcript variant X16
TLD domain-containing protein 2, transcript variant X17
TLD domain-containing protein 2, transcript variant X15
TLD domain-containing protein 2, transcript variant X14
TLD domain-containing protein 2 isoform X12
TLD domain-containing protein 2, transcript variant X18
TLD domain-containing protein 2 isoform X13
uncharacterized LOC122567614, transcript variant X2
uncharacterized LOC122567614, transcript variant X1
N-acetylgalactosaminyltransferase 6-like
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X4
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X1
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X3
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X2
probable ubiquitin carboxyl-terminal hydrolase FAF-X isoform X2
probable ubiquitin carboxyl-terminal hydrolase FAF-X isoform X1
eukaryotic translation initiation factor 2A
growth hormone-regulated TBC protein 1, transcript variant X2
growth hormone-regulated TBC protein 1, transcript variant X1
growth hormone-regulated TBC protein 1 isoform X1
growth hormone-regulated TBC protein 1-A isoform X2
mitochondrial import inner membrane translocase subunit TIM14, transcript variant X2
mitochondrial import inner membrane translocase subunit TIM14, transcript variant X1
mitochondrial import inner membrane translocase subunit TIM14 isoform X2
mitochondrial import inner membrane translocase subunit TIM14 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
histone acetyltransferase type B catalytic subunit
uncharacterized LOC122567307, transcript variant X2
uncharacterized LOC122567307, transcript variant X1
V-type proton ATPase subunit C, transcript variant X1
V-type proton ATPase subunit C, transcript variant X2
V-type proton ATPase subunit C, transcript variant X4
V-type proton ATPase subunit C, transcript variant X5
V-type proton ATPase subunit C, transcript variant X3
membrane-bound transcription factor site-1 protease, transcript variant X2
membrane-bound transcription factor site-1 protease, transcript variant X1
membrane-bound transcription factor site-1 protease isoform X2
membrane-bound transcription factor site-1 protease isoform X1
membrane-bound transcription factor site-1 protease, transcript variant X3
membrane-bound transcription factor site-1 protease isoform X3
DNA ligase 4-like, transcript variant X2
DNA ligase 4-like, transcript variant X1
general transcription factor 3C polypeptide 3-like isoform X2
uncharacterized LOC122567311, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122567309, transcript variant X1
uncharacterized LOC122567309, transcript variant X2
uncharacterized LOC122567309, transcript variant X3
uncharacterized protein LOC122567309 isoform X1
uncharacterized protein LOC122567309 isoform X2
uncharacterized protein LOC122567309 isoform X3
uncharacterized LOC122567311, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
leucine-rich repeat-containing protein 49, transcript variant X3
leucine-rich repeat-containing protein 49 isoform X3
leucine-rich repeat-containing protein 49, transcript variant X4
leucine-rich repeat-containing protein 49, transcript variant X2
leucine-rich repeat-containing protein 49, transcript variant X1
leucine-rich repeat-containing protein 49 isoform X2
leucine-rich repeat-containing protein 49 isoform X1
leucine-rich repeat-containing protein 49 isoform X4
39S ribosomal protein L54, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
39S ribosomal protein L54, mitochondrial, transcript variant X2
39S ribosomal protein L54, mitochondrial isoform X1
39S ribosomal protein L54, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
nuclear export mediator factor NEMF homolog
serine/threonine-protein kinase VRK1-like, transcript variant X2
serine/threonine-protein kinase VRK1-like, transcript variant X1
serine/threonine-protein kinase VRK1-like
serine/threonine-protein kinase greatwall
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein grainyhead, transcript variant X2
protein grainyhead, transcript variant X3
protein grainyhead, transcript variant X1
protein grainyhead, transcript variant X4
zinc finger protein 467, transcript variant X5
zinc finger protein 467, transcript variant X2
regulator of G-protein signaling 17, transcript variant X8
regulator of G-protein signaling 17, transcript variant X6
regulator of G-protein signaling 17, transcript variant X5
regulator of G-protein signaling 17, transcript variant X2
regulator of G-protein signaling 17, transcript variant X4
regulator of G-protein signaling 17, transcript variant X3
regulator of G-protein signaling 17, transcript variant X7
regulator of G-protein signaling 17, transcript variant X1
regulator of G-protein signaling 17 isoform X8
regulator of G-protein signaling 17 isoform X7
regulator of G-protein signaling 17 isoform X6
regulator of G-protein signaling 17 isoform X5
regulator of G-protein signaling 17 isoform X2
regulator of G-protein signaling 17 isoform X4
regulator of G-protein signaling 17 isoform X1
regulator of G-protein signaling 17 isoform X3
zinc finger protein 467, transcript variant X1
zinc finger protein 467, transcript variant X8
zinc finger protein 467, transcript variant X7
zinc finger protein 467, transcript variant X3
zinc finger protein 467, transcript variant X6
zinc finger protein 467, transcript variant X4
uncharacterized protein LOC122567859 isoform X1
uncharacterized protein LOC122567859 isoform X3
uncharacterized protein LOC122567859 isoform X2
zinc finger protein 467, transcript variant X9
uncharacterized LOC122567426, transcript variant X3
uncharacterized LOC122567426, transcript variant X1
uncharacterized LOC122567426, transcript variant X2
neural cell adhesion molecule 1 isoform X1
uncharacterized LOC122567373, transcript variant X1
uncharacterized LOC122567373, transcript variant X2
testis-expressed protein 47-like, transcript variant X1
testis-expressed protein 47-like, transcript variant X2
testis-expressed protein 47-like isoform X1
testis-expressed protein 47-like isoform X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 4
protein PRRC1-B-like, transcript variant X3
protein PRRC1-B-like, transcript variant X2
protein PRRC1-B-like, transcript variant X1
myb-like protein D, transcript variant X6
myb-like protein D, transcript variant X1
myb-like protein D, transcript variant X4
myb-like protein D, transcript variant X7
myb-like protein D, transcript variant X2
myb-like protein D, transcript variant X3
myb-like protein D, transcript variant X5
adipocyte plasma membrane-associated protein-like
uncharacterized LOC122567365, transcript variant X3
uncharacterized LOC122567365, transcript variant X1
uncharacterized LOC122567365, transcript variant X4
uncharacterized LOC122567365, transcript variant X2
uncharacterized protein LOC122567365 isoform X3
uncharacterized protein LOC122567365 isoform X1
uncharacterized protein LOC122567365 isoform X2
probable G-protein coupled receptor Mth-like 1, transcript variant X1
probable G-protein coupled receptor Mth-like 1 isoform X1
probable G-protein coupled receptor Mth-like 1, transcript variant X2
probable G-protein coupled receptor Mth-like 1 isoform X2
probable G-protein coupled receptor Mth-like 5, transcript variant X1
probable G-protein coupled receptor Mth-like 5, transcript variant X2
probable G-protein coupled receptor Mth-like 5, transcript variant X3
probable G-protein coupled receptor Mth-like 5 isoform X1
probable G-protein coupled receptor Mth-like 5 isoform X2
single-strand selective monofunctional uracil DNA glycosylase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
single-strand selective monofunctional uracil DNA glycosylase, transcript variant X1
single-strand selective monofunctional uracil DNA glycosylase isoform X2
single-strand selective monofunctional uracil DNA glycosylase isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
probable tubulin polyglutamylase ttll-15, transcript variant X2
probable tubulin polyglutamylase ttll-15 isoform X2
probable tubulin polyglutamylase ttll-15, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable tubulin polyglutamylase ttll-15 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transmembrane protein 256 homolog, transcript variant X2
transmembrane protein 256 homolog, transcript variant X1
transmembrane protein 256 homolog isoform X1
transmembrane protein 256 homolog isoform X2
zinc finger protein 83, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 83, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B, transcript variant X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B, transcript variant X1
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B isoform X1
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B isoform X2
INO80 complex subunit D, transcript variant X1
INO80 complex subunit D, transcript variant X3
INO80 complex subunit D, transcript variant X4
INO80 complex subunit D, transcript variant X2
INO80 complex subunit D, transcript variant X5
INO80 complex subunit D, transcript variant X6
INO80 complex subunit D, transcript variant X7
uncharacterized LOC122567394, transcript variant X1
uncharacterized LOC122567394, transcript variant X2
uncharacterized LOC122567394, transcript variant X3
HSPB1-associated protein 1, transcript variant X3
HSPB1-associated protein 1, transcript variant X4
HSPB1-associated protein 1, transcript variant X1
HSPB1-associated protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 51% coverage of the annotated genomic feature by RNAseq alignments
uridine diphosphate glucose pyrophosphatase NUDT14-like
beclin-1-like protein, transcript variant X2
beclin-1-like protein, transcript variant X1
beclin-1-like protein, transcript variant X3
uncharacterized LOC122567527, transcript variant X2
uncharacterized LOC122567527, transcript variant X1
homeobox protein homothorax, transcript variant X4
homeobox protein homothorax, transcript variant X2
homeobox protein homothorax, transcript variant X5
homeobox protein homothorax, transcript variant X3
homeobox protein homothorax, transcript variant X1
uncharacterized LOC122567955, transcript variant X1
uncharacterized protein LOC122567955 isoform X1
uncharacterized LOC122567955, transcript variant X2
uncharacterized protein LOC122567955 isoform X2
exosome complex component RRP46, transcript variant X1
exosome complex component RRP46 isoform X1
exosome complex component RRP46, transcript variant X3
exosome complex component RRP46, transcript variant X2
exosome complex component RRP46 isoform X2
radial spoke head protein 6 homolog A, transcript variant X2
radial spoke head protein 6 homolog A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
radial spoke head protein 6 homolog A isoform X1
radial spoke head protein 6 homolog A isoform X2
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1-like
two pore potassium channel protein sup-9, transcript variant X6
two pore potassium channel protein sup-9, transcript variant X9
two pore potassium channel protein sup-9, transcript variant X7
two pore potassium channel protein sup-9, transcript variant X8
two pore potassium channel protein sup-9, transcript variant X5
two pore potassium channel protein sup-9, transcript variant X2
two pore potassium channel protein sup-9, transcript variant X10
two pore potassium channel protein sup-9, transcript variant X4
two pore potassium channel protein sup-9, transcript variant X3
two pore potassium channel protein sup-9, transcript variant X11
two pore potassium channel protein sup-9, transcript variant X1
two pore potassium channel protein sup-9 isoform X1
two pore potassium channel protein sup-9 isoform X2
muscle M-line assembly protein unc-89-like
uncharacterized LOC122567526, transcript variant X4
uncharacterized LOC122567526, transcript variant X1
uncharacterized LOC122567526, transcript variant X3
uncharacterized LOC122567515, transcript variant X1
uncharacterized protein LOC122567515 isoform X1
uncharacterized LOC122567526, transcript variant X5
uncharacterized LOC122567515, transcript variant X2
uncharacterized protein LOC122567515 isoform X2
uncharacterized LOC122567526, transcript variant X6
uncharacterized LOC122567526, transcript variant X7
uncharacterized LOC122567526, transcript variant X2
tryptophan--tRNA ligase, cytoplasmic, transcript variant X1
tryptophan--tRNA ligase, cytoplasmic, transcript variant X2
tryptophan--tRNA ligase, cytoplasmic isoform X1
tryptophan--tRNA ligase, cytoplasmic isoform X2
protein phosphatase 1B, transcript variant X4
protein phosphatase 1B, transcript variant X1
protein phosphatase 1B, transcript variant X3
protein phosphatase 1B, transcript variant X2
beclin 1-associated autophagy-related key regulator, transcript variant X1
beclin 1-associated autophagy-related key regulator, transcript variant X2
beclin 1-associated autophagy-related key regulator isoform X2
beclin 1-associated autophagy-related key regulator isoform X1
probable cleavage and polyadenylation specificity factor subunit 2, transcript variant X2
probable cleavage and polyadenylation specificity factor subunit 2, transcript variant X1
probable cleavage and polyadenylation specificity factor subunit 2
uncharacterized LOC122567520, transcript variant X2
uncharacterized LOC122567520, transcript variant X1
spliceosome-associated protein CWC27 homolog
uncharacterized LOC122567979, transcript variant X3
uncharacterized LOC122567979, transcript variant X4
uncharacterized LOC122567979, transcript variant X2
uncharacterized protein LOC122567979 isoform X2
uncharacterized protein LOC122567979 isoform X3
uncharacterized LOC122567979, transcript variant X1
uncharacterized protein LOC122567979 isoform X1
uncharacterized protein LOC122567979 isoform X4
uncharacterized LOC122567976, transcript variant X9
uncharacterized LOC122567976, transcript variant X8
uncharacterized LOC122567976, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122567976, transcript variant X2
uncharacterized LOC122567976, transcript variant X4
uncharacterized LOC122567976, transcript variant X5
uncharacterized LOC122567976, transcript variant X3
uncharacterized LOC122567976, transcript variant X6
uncharacterized LOC122567976, transcript variant X1
uncharacterized LOC122567976, transcript variant X11
uncharacterized LOC122567976, transcript variant X10
uncharacterized protein LOC122567976 isoform X2
uncharacterized protein LOC122567976 isoform X1
uncharacterized protein LOC122567976 isoform X3
putative ferric-chelate reductase 1 homolog, transcript variant X2
putative ferric-chelate reductase 1 homolog, transcript variant X1
putative ferric-chelate reductase 1 homolog isoform X1
putative ferric-chelate reductase 1 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein FAM117B-like, transcript variant X2
protein FAM117B-like, transcript variant X1
tripartite motif-containing protein 2-like, transcript variant X3
tripartite motif-containing protein 2-like, transcript variant X1
tripartite motif-containing protein 2-like, transcript variant X2
tripartite motif-containing protein 2-like, transcript variant X5
tripartite motif-containing protein 2-like, transcript variant X7
tripartite motif-containing protein 2-like, transcript variant X4
tripartite motif-containing protein 2-like, transcript variant X6
tripartite motif-containing protein 2-like isoform X3
tripartite motif-containing protein 2-like isoform X5
tripartite motif-containing protein 2-like isoform X2
tripartite motif-containing protein 2-like isoform X1
tripartite motif-containing protein 2-like isoform X4
tripartite motif-containing protein 2-like isoform X6
chymotrypsin-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
chymotrypsin-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
DNA polymerase iota, transcript variant X3
DNA polymerase iota, transcript variant X2
DNA polymerase iota, transcript variant X1
E3 SUMO-protein ligase PIAS2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
E3 SUMO-protein ligase PIAS2, transcript variant X4
E3 SUMO-protein ligase PIAS2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
E3 SUMO-protein ligase PIAS2, transcript variant X3
acetylcholine receptor subunit beta-like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 255 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
acetylcholine receptor subunit beta-like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 255 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
acetylcholine receptor subunit beta-like 2 isoform X2
acetylcholine receptor subunit beta-like 2 isoform X1
hemicentin-2-like, transcript variant X3
hemicentin-2-like, transcript variant X5
hemicentin-2-like, transcript variant X4
hemicentin-2-like, transcript variant X7
hemicentin-2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 128 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122568005, transcript variant X1
uncharacterized LOC122568005, transcript variant X2
major antigen-like, transcript variant X1
major antigen-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
26S proteasome non-ATPase regulatory subunit 9
tetratricopeptide repeat protein 30A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tetratricopeptide repeat protein 30A, transcript variant X4
tetratricopeptide repeat protein 30A, transcript variant X3
tetratricopeptide repeat protein 30A, transcript variant X1
tetratricopeptide repeat protein 30A isoform X2
tetratricopeptide repeat protein 30A isoform X1
tetratricopeptide repeat protein 30A isoform X3
nucleolar protein of 40 kDa-like, transcript variant X1
nucleolar protein of 40 kDa-like, transcript variant X2
nucleolar protein of 40 kDa-like isoform X1
nucleolar protein of 40 kDa-like isoform X2
cyclin-dependent kinase-like 4, transcript variant X1
cyclin-dependent kinase-like 4, transcript variant X3
cyclin-dependent kinase-like 4, transcript variant X2
cyclin-dependent kinase-like 4 isoform X1
cyclin-dependent kinase-like 4 isoform X3
cyclin-dependent kinase-like 4 isoform X2